Related Experiment Video
Updated: Jan 22, 2026
Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Chylothorax and Chylous-Like Diseases in Children: Clinical Management
Michael Hermon1, Elias Tenner2, Gudrun Burda1
1Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria.
Insights
Chylothorax in children is often post-surgical and treatable with conservative therapies like MBF/MCT. Early diagnosis and treatment are key to preventing complications and improving outcomes in these rare, serious conditions.
Area of Science:
- Pediatric critical care medicine
- Thoracic surgery
- Gastroenterology
Background:
- Chylothorax and chylous-like diseases are rare, potentially life-threatening pediatric conditions.
- These disorders can cause significant morbidity and prolonged hospitalizations, particularly in critically ill children.
- Current treatment strategies lack established guidelines, necessitating evaluation of existing management approaches.
Purpose of the Study:
- To conduct a comprehensive evaluation of demographic data and clinical management of pediatric patients diagnosed with chylothorax or chylous-like diseases.
- To assess the effectiveness of various therapeutic interventions, including conservative and surgical options.
- To identify factors influencing treatment success and potential areas for guideline development.
Main Methods:
- A retrospective analysis of pediatric intensive care unit admissions between 1999 and 2012.
- Inclusion criteria comprised all children diagnosed with chylothorax or chylous-like diseases.
- Data collected included patient demographics, etiology of the condition, and therapeutic interventions received.
Main Results:
- Thirty-four pediatric patients were analyzed; 91% developed chylothorax post-surgery.
- All patients received milk-fat-free (MBF)/medium-chain triglyceride (MCT) therapy, with significant reduction in chest tube output in 14 patients treated solely with this method.
- Somatostatin was administered to 32% and beta-isodona to 20% of patients; surgical interventions were performed in 17%.
Conclusions:
- A combination of conservative therapies, particularly MBF/MCT, proved successful in managing most pediatric chylothorax cases.
- Early diagnosis, prevention, and prompt treatment of complications are crucial for enhancing conservative therapy success, especially in postoperative chylothorax.
- Appropriate, though potentially lengthy, therapy can significantly reduce morbidity and mortality associated with chylothorax.
Abstract:
Background: Chylothorax and chylous-like diseases are rare conditions and difficult to treat. But they may represent potentially life-threatening disorders and important causes of morbidity and prolonged hospitalization, especially in critically ill children. Conservative as well as surgical therapeutic management strategies are continuously performed at our institution, however the results have never been evaluated and no guidelines for treatment recommendations have been put into practice so far. The objective of this retrospective study was to present a comprehensive and substantial evaluation of all relevant demographic data from children with the chylothorax and chylous-like diseases and their clinical management. Methods: We retrospectively analyzed data from all children with diagnoses of chylothorax and chylous-like diseases admitted to our pediatric intensive care unit between the years 1999 and 2012. Results: Data of 34 patients were analyzed for this study. Gender distribution (M/F) was almost equal (19/15; 56%/44%). Thirty-one children (91%) developed chylothorax after surgery. Two children (6%) had idiopathic chylothorax and in one child (3%) congenital chylothorax was diagnosed. All study patients (n = 34; 100%) received MBF/MCT therapy. We were quite successful in treating 14 children who received only this therapy, with chest tube output dropping from 100 to 4.7%. But only 11 (32%) children received somatostatin and 7 (20%) children received beta-isodona. Different surgical interventions were performed in 6 patients (17%). All study patients received chest tubes to drain the pleural fluid and hence to relieve the chyle related symptoms. Conclusion: A combination of different conservative therapies was successful in most of our patients. Prevention, early diagnosis and treatment of potential complications may further improve the success rate of conservative therapy especially in patients with postoperative chylothorax. In summary, appropriate therapy of this condition may be lengthy but can prevent significant morbidity and mortality.
Related Concept Videos
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:28Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
01:21Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:26Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...